These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 12811476)

  • 1. Prognostic significance of Bcl-2 and p53 expression in gastric cancer.
    Lee HK; Lee HS; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
    Int J Colorectal Dis; 2003 Nov; 18(6):518-25. PubMed ID: 12811476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of biological apoptosis factors in gastric cancer.
    Sezer C; Yildirim M; Yildiz M; Sezgin A; Donem Dilli U; Goktas S; Bulbuller N
    J BUON; 2013; 18(1):138-46. PubMed ID: 23613399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.
    Ichiyoshi Y; Oiwa H; Tomisaki S; Sakaguchi Y; Ohno S; Maehara Y; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):546-53. PubMed ID: 9164535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma.
    Fricke E; Keller G; Becker I; Rosivatz E; Schott C; Plaschke S; Rudelius M; Hermannstädter C; Busch R; Höfler H; Becker KF; Luber B
    Int J Cancer; 2003 Mar; 104(1):60-5. PubMed ID: 12532420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins.
    Pan W; Ishii H; Ebihara Y; Gobe G
    J Surg Oncol; 2003 Feb; 82(2):104-10. PubMed ID: 12561066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular markers in gastric cancer: can p53 and bcl-2 protein expressions be used as prognostic factors?
    Zafirellis K; Karameris A; Milingos N; Androulakis G
    Anticancer Res; 2005; 25(5):3629-36. PubMed ID: 16101192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 expression as a prognostic factor of survival of gastric carcinoma.
    Inada T; Kikuyama S; Ichikawa A; Igarashi S; Ogata Y
    Anticancer Res; 1998; 18(3B):2003-10. PubMed ID: 9677457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein expression of bax, bcl-2, and p53 in patients with non-Hodgkin's gastric lymphoma: prognostic significance.
    Charalambous GK; Gomatos IP; Konstadoulakis MM; Messaris EG; Manouras AJ; Apostolou AE; Leandros EA; Karayannis MK; Androulakis GA
    World J Surg; 2000 May; 24(5):608-14. PubMed ID: 10787085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
    Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
    Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of p53 and bcl-2 immunoreactivity for early invasive pT1/pT2 gastric carcinomas: indicators for limited gastric resections?
    Kopp R; Diebold J; Dreier I; Cramer C; Glas J; Baretton G; Jauch KW
    Surg Endosc; 2005 Nov; 19(11):1507-12. PubMed ID: 16177872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer.
    Neri A; Marrelli D; Roviello F; DeMarco G; Mariani F; DeStefano A; Megha T; Caruso S; Corso G; Cioppa T; Pinto E
    Breast Cancer Res Treat; 2006 Sep; 99(1):77-83. PubMed ID: 16541314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancer.
    Jansen RL; Joosten-Achjanie SR; Volovics A; Arends JW; Hupperets PS; Hillen HF; Schouten HC
    Anticancer Res; 1998; 18(6A):4455-62. PubMed ID: 9891509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.
    Apolinario RM; van der Valk P; de Jong JS; Deville W; van Ark-Otte J; Dingemans AM; van Mourik JC; Postmus PE; Pinedo HM; Giaccone G
    J Clin Oncol; 1997 Jun; 15(6):2456-66. PubMed ID: 9196162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Mcl-1 and p53 proteins predicts the survival of patients with T3 gastric carcinoma.
    Maeta Y; Tsujitani S; Matsumoto S; Yamaguchi K; Tatebe S; Kondo A; Ikeguchi M; Kaibara N
    Gastric Cancer; 2004; 7(2):78-84. PubMed ID: 15224193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of bcl-2 expression in gastric cancer.
    Müller W; Schneiders A; Hommel G; Gabbert HE
    Anticancer Res; 1998; 18(6B):4699-704. PubMed ID: 9891543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial cell turnover, p53 and bcl-2 protein expression during oncogenesis of early and advanced gastric cancer in a Western population.
    Triantafyllou K; Kitsanta P; Karamanolis DG; Kittas C; Ladas SD
    Dig Liver Dis; 2008 Jan; 40(1):39-45. PubMed ID: 18063429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and prognostic significance of p53, Ki-67, and Bcl-2 expression in Tunisian gastric adenocarcinomas.
    Ayed DB; Khabir A; Abid M; Bayrouti MI; Gargouri A; Sellami-Boudawara T; Mokdad-Gargouri R
    Acta Histochem; 2014 Oct; 116(8):1244-50. PubMed ID: 25095748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.